logo
logo
Sign in

Regenerative medicines segment contributing large share

avatar
Pooja Khodke
Regenerative medicines segment contributing large share

The global Stem Cells Market is estimated to be valued at US$ 12.9 Bn in 2023 and is expected to exhibit a CAGR of 9.1% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:


Stem cells have the potential to become any cell type within the human body and can serve as a repair system for the body. They may help regeneration of specific tissues and help treat diseases like heart disease, diabetes, and neurodegenerative disorders. Stem cell therapy holds promise to treat debilitating and incurable conditions.


Market key trends:


One of the key trends in the stem cells market is the increasing utilization of stem cells in regenerative medicines. Regenerative medicine aims to regrow, repair or replace damaged or diseased cells, organs or tissues using stem cells and tissue engineering techniques. Some areas that could benefit greatly from these types of therapies include regeneration of cardiac muscles after a heart attack, repair of spinal cord injuries, treatment of diabetes by regeneration of pancreatic islet cells, and vision loss.


Segment Analysis


The global stem cells market is segmented based on cell source, therapeutic application, and region. By cell source, the market is divided into adult stem cells, human embryonic stem cells, induced pluripotent stem cells, and others. The adult stem cells segment currently dominates the market due to fewer ethical issues associated with its use and higher acceptability. Adult stem cells can be isolated from various tissues such as bone marrow, peripheral blood, umbilical cord blood, and adipose tissue.


Key Takeaways


The global Stem Cells Market size is expected to reach US$ 12.9 Bn in 2023, exhibiting a CAGR of 9.1% over the forecast period of 2023-2030, due to increasing incidence of chronic diseases.


The US dominates the stem cells market owing to the presence of advanced healthcare infrastructure and higher healthcare spending. Asia Pacific is expected to witness the fastest growth due to rising medical tourism industry and increasing incidence of chronic diseases in nations such as India and China.


Key players operating in the stem cells market are Advanced Cell Technology, Inc., Angel Biotechnology Holdings PLC, Biotricity, Lineage Cell Therapeutics, Inc., BrainStorm Cell Limited., CIRM, Celgene Corporation (A subsidiary of Bristol-Myers Squibb Company), Takara Bio Inc., Cellular Engineering Technologies., Cytori Therapeutics Inc., and STEMCELL Technologies. Advanced Cell Technology specializes in regenerative medicine and plans to target ophthalmology as one of its therapeutic areas using stem cell therapy.



Read More :  https://www.newsstatix.com/stem-cells-market-estimated-to-witness-high-growth-owing-to-rising-prevalence-of-chronic-diseases-and-increasing-rd-investments/

collect
0
avatar
Pooja Khodke
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more